Carson Lamb
- T. 404-815-3678
- F. 404-685-6978
- clamb@sgrlaw.com
Legal Assistant: Alicia Nichols | 404-815-3939
Known for combining deep regulatory knowledge with practical transactional insight, Carson works closely with clients on day-to-day operational challenges, high-stakes strategic initiatives, and complex transactions requiring coordinated legal, business, and regulatory analysis.
About Carson
Carson Lamb advises healthcare providers, investors, management companies, and emerging growth businesses operating in highly regulated and transaction-intensive environments. Carson’s practice sits at the intersection of complex transactions, regulatory risk, and real‑world business execution. With more than a decade of experience, he advises hospitals, health systems, physician groups, investors, and private equity‑backed platforms on how to structure, close, and operate in those industries where legal and economic models are tightly intertwined.
A significant portion of Carson’s practice is dedicated to representing private equity sponsors and their portfolio companies in healthcare investments. He regularly leads acquisitions, roll‑ups, and platform transactions, structuring MSO models, physician alignment strategies, and multi‑entity deal frameworks that comply with corporate practice of medicine and fraud and abuse laws without sacrificing commercial objectives. He brings particular strength in translating regulatory constraints into workable deal structures that actually close—and hold up post‑closing.
Carson is not just a deal lawyer. He is a day‑to‑day advisor who works alongside operators and investors as they make ongoing business decisions. He advises on physician compensation models, referral relationships, contracting strategies, and operational structure, helping clients move quickly without creating hidden compliance exposure. When issues arise, his clients bring him in to untangle them, whether that means resolving disputes, re‑papering arrangements, or addressing post‑closing liability.
Clients rely on Carson when the answers are not obvious and the path forward is not clean. He is known for cutting through complexity, identifying what actually matters, and giving clear, actionable guidance. His approach is practical, direct, and commercially focused: he understands how deals are priced, how platforms are built, and how cash flows in these structures—and he aligns the legal solution accordingly.
In addition to his healthcare expertise, Carson advises clients on a broad range of corporate and finance matters, including complex commercial arrangements, investment and ownership structures, portfolio company operations, capital raises, founder and investor relationships, and strategic growth initiatives. He regularly assists clients in evaluating and structuring sophisticated business arrangements involving management companies, investment vehicles, operational platforms, and affiliated entities, with a focus on aligning legal strategy with broader business and financial objectives.
Known for combining deep regulatory knowledge with practical transactional insight, Carson works closely with clients on operational challenges, high-stakes strategic initiatives, and complex transactions requiring coordinated legal, business, and regulatory analysis. He is particularly valued for his ability to navigate client matters in a manner that is both commercially pragmatic and operationally effective. In the spaces where legal advice can slow momentum, Carson’s value is the opposite, helping clients move forward with clarity and confidence.
Carson's Practice
Representative Matters
- Represent private equity sponsors and portfolio companies in the formation, acquisition, and scaling of healthcare platforms, structuring MSO-led “friendly physician” models, equity rollovers, and physician alignment frameworks that balance regulatory constraints with sponsor return objectives.
- Lead buy-side and sell-side transactions for PE-backed healthcare investments, including platform acquisitions, add-on deals, and complex equity/asset hybrids, with a focus on preserving deal economics through disciplined risk allocation and regulatory structuring.
- Advise sponsors and executives on post-acquisition integration and operational alignment, including restructuring legacy arrangements, implementing standardized MSAs, and addressing compensation and referral model compliance across multi-entity platforms.
- Counsel clients on sophisticated physician compensation models and incentive structures, including productivity-based compensation, profit participation, and hybrid equity arrangements, ensuring alignment with Stark and Anti-Kickback law while maintaining commercial viability.
- Serve as lead counsel on multi-state healthcare transactions involving overlapping regulatory regimes, coordinating diligence, structuring, and documentation across clinical and non-clinical entities and affiliated service lines.
- Lead resolution of complex post-closing disputes and exposure events, including indemnification claims, purchase price adjustments, and undisclosed liabilities, with a focus on achieving commercially practical outcomes without disrupting platform operations.
- Provide day-to-day strategic and regulatory counsel to healthcare providers, suppliers, operators, and investors, guiding real-time decisions on compliance, contracting, fraud and abuse, and operational structure, enabling clients to move quickly while managing regulatory risk.
Credentials
Education
J.D., Georgia State University College of Law
B.A., University of South Carolina
Admissions
- Georgia
- Iowa
Organizational Involvement
Professional
American Health Lawyers Association
American Society for Pharmacy Law
Board Member, High Point Civic Association
Committee Member, ACG Atlanta
Georgia Bar Health Law Section
Health Care Compliance Association
Community
Board Member, Enduring Hearts
Thought Leadership
- Health Care Fraud Law: A 50 State Survey (Iowa), Lamb, Carson et al., First Edition, American Health Law Association, (2022)
- “Nursing Facilities and CMPs: The Latest Fight” February 10, 2021, Dorsey Health Law Blog (February 2021)
- “White Paper: Understanding the Final Rules to Revise the Anti-Kickback Statute and Beneficiary Inducement Civil Monetary Penalties Regulations” Dorsey Health Law Blog (January 2021)
- “White Paper: Understanding the Final Rules to Revise the Stark Law Regulations” Dorsey Health Law Blog (January 2021)
- “CMS Providers Additional COVID-19 EMTALA Guidance for Hospitals” Dorsey Health Law Blog (May 2020)
- “The Paycheck Protection Program and Health Care Enhancement Act: Summary of ‘Phase 3.5’ COVID-19 Stimulus Package” Dorsey Health Law Blog (April 2020)
- “CARES Act Summary of Provisions that Support America’s Health Care System” Dorsey Health Law Blog, (March 2020)
- “COVID-19 and EMTALA: Ongoing Requirements and New Waivers” March 23, 2020, Dorsey Health Law Blog (March 2020)
- “OIG’s Latest Congressional Report Sees Continued Emphasis on Fraud and Abuse Enforcement” Dorsey Health Law Blog, (January 2020)
- “VA, OIG Form New Health Fraud Task Force” Contributor, HLBytes, American Bar Association, (2019)